fda warning bpc-157 not approved safety concerns Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY ⬇️ Stuffy nose? Reach for phenylephrine!
Stuffy nose? Reach for phenylephrine! Well, not anymore. Last week, the FDA announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in OTC drug products FDA to discuss easing restrictions on peptides despite safety concerns US healthcare The Guardian FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. AP News The future of peptides in the US is about to become clearer. Here's what you should know CNN
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

